Trading at 275x free cash flow with first-ever debt assumption, ISRG offers 0.40% earnings yield versus 4.33% treasuries.
This framework sees a magnificent business trading at a price that abandons every principle of conservative investing.
Does the price protect me from permanent loss of capital?
This framework sees no margin of safety whatsoever. The price demands not just continued excellence but acceleration of an already exceptional growth rate. At 337% above intrinsic value, any stumble in execution or market sentiment would trigger severe capital loss.
Does the equity risk premium justify choosing this over treasuries?
Applying this lens reveals an investment offering one-eleventh the yield of risk-free treasuries. Even with 20% growth, it would take years of flawless execution to justify this spread. The framework sees this as speculation on growth, not investment for income.
What do I receive in earnings and assets per dollar of price?
This framework calculates you receive almost nothing tangible for each dollar invested. The price reflects not current fundamentals but hopes for a distant future. Conservative investing requires buying assets and earnings cheaply, not expensively.
Has management demonstrated consistent earnings over many years?
Through this lens, the framework acknowledges exceptional execution. Management has delivered consistent earnings growth through multiple cycles. The 92.3% beat rate over 39 quarters represents exactly the kind of demonstrated competence this framework values.
Applying this framework reveals a paradox: one of the finest businesses in healthcare trading at one of the most dangerous valuations in the market. The framework recognizes the exceptional earnings record and operational excellence, but these virtues are overwhelmed by a price that offers no margin of safety, an earnings yield dwarfed by treasuries, and euphoric sentiment that punishes any imperfection. Conservative principles demand avoiding such situations regardless of business quality. What catastrophe must occur for this price to offer genuine value?
This analysis applies Benjamin Graham's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Benjamin Graham. Educational purposes only. Not financial advice.